Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer

OBJECTIVE: To compare the efficacy and toxicity of dose-dense weekly paclitaxel and 3-weekly carboplatin (ddPC) as neoadjuvant chemotherapy (NAC) with the standard 3-weekly regimen. METHODS: A retrospective study of patients diagnosed with stage IIIc and IV ovarian cancer who received at least one c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yoo-Na, Lee, Yong Jae, Lee, Jung-Yun, Nam, Eun Ji, Kim, Sang Wun, Kim, Sunghoon, Kim, Young Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044004/
https://www.ncbi.nlm.nih.gov/pubmed/31912678
http://dx.doi.org/10.3802/jgo.2020.31.e23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044004/
https://www.ncbi.nlm.nih.gov/pubmed/31912678
http://dx.doi.org/10.3802/jgo.2020.31.e23

Ejemplares similares